1932

Abstract

The increase in drug-resistant pathogenic bacteria has created an urgent demand for new antibiotics. Among the more attractive targets for the development of new antibacterial compounds are the enzymes of fatty acid biosynthesis. Although a number of potent inhibitors of microbial fatty acid biosynthesis have been discovered, few of these are clinically useful drugs. Several of these fatty acid biosynthesis inhibitors have potential as lead compounds in the development of new antibacterials. This review encompasses the known inhibitors and prospective targets for new antibacterials.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.micro.55.1.305
2001-10-01
2024-06-14
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.micro.55.1.305
Loading
/content/journals/10.1146/annurev.micro.55.1.305
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error